New court documents have revealed more details about the condition of death row inmate Christa Pike after a failed execution attempt in Tennessee.
Pike was scheduled to be executed on Sept. 30. She survived after receiving two doses of pentobarbital, the drug used in Tennessee’s lethal injection process. The incident has led to fresh legal challenges and renewed questions about the state’s execution procedures.
An emergency court filing submitted on Oct. 2 seeks to preserve all evidence related to the execution attempt. Pike’s attorneys argue that mistakes during the procedure may have caused the execution to fail and that important evidence must be protected.
The filing states that Pike remained alive and in critical condition as of the night of Oct. 1. According to the document, she was unconscious, intubated, and connected to a ventilator at a hospital near Nashville.
The filing also described injuries to both of Pike’s arms. It said they were swollen and covered with burns and blisters following the attempted execution.
Lawyers said medical staff were working to clear pentobarbital from her body while trying to save her life.
A judge was reviewing the emergency request shortly after it was filed. No hearing date had been announced.
Pike is the only woman on Tennessee’s death row. She was convicted of the murder of 19-year-old Colleen Slemmer and sentenced to death in 1996.
The execution was delayed for several hours because of legal developments on Sept. 30. The procedure had originally been scheduled for the morning but did not move forward until later in the day.
Witnesses who observed the process reported several interruptions. They said blinds to the viewing area opened and closed multiple times during the procedure. As witnesses left the facility later that evening, they reported hearing Pike continue to breathe.
The emergency filing claims the execution team failed to recognize problems with the intravenous lines used to administer the drug.
According to the document, Pike’s veins may have collapsed during the process. Her attorneys argued that the pentobarbital may not have entered her bloodstream correctly.
The filing states that officials then prepared another set of syringes and administered a second dose of the drug.
Despite receiving two doses, Pike survived.
Her legal team described the state’s actions as a serious failure. Attorneys argued that officials did not properly address signs that the drug delivery process was not working as intended.
State officials have defended their actions.
After the execution attempt, officials said every step of the approved protocol had been followed. They also stated that the protocol did not allow additional medical procedures beyond those already outlined.
On Oct. 1, Pike’s attorney Randy Spivey confirmed that she was still alive and receiving emergency treatment.
He said doctors were continuing to provide life-saving care. However, he noted that her long-term outlook remained uncertain.
No additional medical updates were released by Oct. 2.
The case that sent Pike to death row dates back to January 1995.
Prosecutors said Pike and her boyfriend, Tadaryl Shipp, lured Slemmer to a park in Knoxville. Investigators said the victim was beaten and tortured before being killed.
Authorities also reported that a pentagram was carved into Slemmer’s body during the attack.
Pike was found guilty of first-degree murder the following year. Shipp was also convicted in the case.
A third person, Shadolla Peterson, later testified and received probation.
Slemmer grew up in Orange Park, Florida. Family members and friends remembered her as a talented young woman who volunteered in her community and supported local activities.
The failed execution has attracted attention from legal experts and medical professionals across the country.
Some experts have suggested that an IV failure or another drug delivery problem may be the most likely explanation for Pike’s survival. However, no official findings have been released.
Questions had been raised before the execution about Pike’s health. Her lawyers pointed to thrombocytosis, a blood condition they believed could complicate the lethal injection process.
They also expressed concerns about whether reliable IV access could be established.
As investigations continue, the Tennessee Failed Execution case is expected to play a major role in ongoing legal disputes over the state’s use of lethal injection. The outcome could shape future discussions about execution procedures and inmate rights in Tennessee.
